Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 11.

Koeberle, D; Betticher, D C; von Moos, R; Dietrich, D; Brauchli, P; Baertschi, D; Matter, K; Winterhalder, R; Borner, M; Anchisi, S; Moosmann, P; Kollar, A; Saletti, P; Roth, A; Frueh, M; Kueng, M; Popescu, R A; Schacher, S; Hess, V; Herrmann, R (2015). Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06). Annals of Oncology, 26(4):709-714.

Roth, P; Martus, P; Kiewe, P; Mohle, R; Klasen, H; Rauch, M; Roth, A; Kaun, S; Thiel, E; Korfel, A; Weller, M (2012). Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial. Neurology, 79(9):890-896.

Powell, S; Szklarczyk, D; Trachana, K; Roth, A; Kuhn, M; Muller, J; Arnold, R; Rattei, T; Letunic, I; Doerks, T; Jensen, L J; von Mering, C; Bork, P (2012). eggNOG v3.0: orthologous groups covering 1133 organisms at 41 different taxonomic ranges. Nucleic Acids Research, 40(D1):D284-D289.

Rentrop, M; Roth, A; Rodewald, K; Simon, J; Metzler, S; Walther, S; Weisbrod, M; Kaiser, S (2011). Temporal variability and spatial diffusion of the N2 event-related potential in high-functioning patients with schizophrenia. Schizophrenia Research, 131(1-3):206-213.

Szklarczyk, D; Franceschini, A; Kuhn, M; Simonovic, M; Roth, A; Minguez, P; Doerks, T; Stark, M; Muller, J; Bork, P; Jensen, L J; von Mering, C (2011). The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Research, 39(Sup 1):D561-D568.

Thiel, E; Korfel, A; Martus, P; Kanz, L; Griesinger, F; Rauch, M; Roth, A; Hertenstein, B; von Toll, T; Hundsberger, T; Mergenthaler, H G; Leithäuser, M; Birnbaum, T; Fischer, L; Jahnke, K; Herrlinger, U; Plasswilm, L; Nägele, T; Pietsch, T; Bamberg, M; Weller, M (2010). High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncology, 11(11):1036-1047.

Rentrop, M; Rodewald, K; Roth, A; Simon, J; Walther, S; Fiedler, P; Weisbrod, M; Kaiser, S (2010). Intra-individual variability in high-functioning patients with schizophrenia. Psychiatry Research, 178(1):27-32.

Muller, J; Szklarczyk, D; Julien, P; Letunic, I; Roth, A; Kuhn, M; Powell, S; von Mering, C; Doerks, T; Jensen, L J; Bork, P (2010). eggNOG v2.0: extending the evolutionary genealogy of genes with enhanced non-supervised orthologous groups, species and functional annotations. Nucleic Acids Research, 38 (Da:D190-D195.

Jensen, L J; Kuhn, M; Stark, M; Chaffron, S; Creevey, C; Muller, J; Doerks, T; Julien, P; Roth, A; Simonovic, M; Bork, P; von Mering, C (2009). STRING 8--a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Research, 37(Databa):D412-D416.

Borner, M; Koeberle, D; Von Moos, R; Saletti, P; Rauch, D; Hess, V; Trojan, A; Helbling, D; Pestalozzi, B; Caspar, Christian; Ruhstaller, T; Roth, A; Kappeler, A; Dietrich, D; Lanz, D; Mingrone, W (2008). Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the swiss group for clinical cancer research SAKK. Annals of Oncology, 19(7):1288 -1292 .

Handschin, C; Blättler, S; Roth, A; Looser, R; Oscarson, M; Kaufmann, M R; Podvinec, M; Gnerre, C; Meyer, U A (2004). The evolution of drug-activated nuclear receptors: one ancestral gene diverged into two xenosensor genes in mammals. Nuclear Receptor, 2:7.

This list was generated on Thu Oct 19 02:45:08 2017 CEST.